Literature DB >> 11024057

The role of histidine 632 in catalysis by human topoisomerase I.

Z Yang1, J J Champoux.   

Abstract

Based on the crystal structure of human topoisomerase I, we hypothesized that hydrogen bonding between the side chain of the highly conserved His(632) and one of the nonbridging oxygens of the scissile phosphate contributes to catalysis by stabilizing the transition state. This hypothesis has been tested by examining the effects of changing His(632) to glutamine, asparagine, alanine, and tryptophan. The change to glutamine reduced both the relaxation activity and single-turnover cleavage activity by approximately 100-fold, whereas the same change at three other conserved histidines (positions 222, 367, and 406) had no significant effect on the relaxation activity. The properties of the mutant protein containing asparagine instead of histidine at position 632 were similar to those of the glutamine mutant, whereas mutations to alanine or tryptophan reduced the activity by approximately 4 orders of magnitude. The reduction in activity for the mutants was not due to alterations in substrate binding affinities or changes in the cleavage specificities of the proteins. The above results for the glutamine mutation in conjunction with the similar effects of pH on the wild type and the H632Q mutant enzyme rule out the possibility that His(632) acts as a general acid to protonate the leaving 5'-oxygen during the cleavage reaction. Taken together, these data strongly support the hypothesis that the only role for His(632) is to stabilize the pentavalent transition state through hydrogen bonding to one of the nonbridging oxygens.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11024057     DOI: 10.1074/jbc.M007593200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  7 in total

1.  Biochemical characterization of the topoisomerase domain of Methanopyrus kandleri topoisomerase V.

Authors:  Rakhi Rajan; Amy K Osterman; Alexandra T Gast; Alfonso Mondragón
Journal:  J Biol Chem       Date:  2014-08-18       Impact factor: 5.157

Review 2.  Topoisomerases as anticancer targets.

Authors:  Justine L Delgado; Chao-Ming Hsieh; Nei-Li Chan; Hiroshi Hiasa
Journal:  Biochem J       Date:  2018-01-23       Impact factor: 3.857

Review 3.  DNA topoisomerases in apicomplexan parasites: promising targets for drug discovery.

Authors:  Carlos García-Estrada; Christopher Fernández Prada; Celia Fernández-Rubio; Francisco Rojo-Vázquez; Rafael Balaña-Fouce
Journal:  Proc Biol Sci       Date:  2010-03-03       Impact factor: 5.349

Review 4.  Topoisomerases and site-specific recombinases: similarities in structure and mechanism.

Authors:  Wei Yang
Journal:  Crit Rev Biochem Mol Biol       Date:  2010-12       Impact factor: 8.250

5.  Mutational analysis of the preferential binding of human topoisomerase I to supercoiled DNA.

Authors:  Zheng Yang; James F Carey; James J Champoux
Journal:  FEBS J       Date:  2009-09-09       Impact factor: 5.542

6.  ATP independent type IB topoisomerase of Leishmania donovani is stimulated by ATP: an insight into the functional mechanism.

Authors:  Souvik Sengupta; Agneyo Ganguly; Amit Roy; Somdeb Bosedasgupta; Ilda D'Annessa; Alessandro Desideri; Hemanta K Majumder
Journal:  Nucleic Acids Res       Date:  2010-12-23       Impact factor: 16.971

Review 7.  Structural studies of type I topoisomerases.

Authors:  Nicole M Baker; Rakhi Rajan; Alfonso Mondragón
Journal:  Nucleic Acids Res       Date:  2008-12-23       Impact factor: 16.971

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.